Portal de Periódicos da CAPES

Different receptor subtypes mediate the dual presynaptic effects of 5‐hydroxytryptamine on peripheral sympathetic neurones

1989; Wiley; Volume: 9; Issue: 1 Linguagem: Inglês

10.1111/j.1474-8673.1989.tb00191.x

1365-2680

Edda Adler‐Graschinsky, Ana Belén Elgoyhen, Nora Butta,

Pharmacological Receptor Mechanisms and Effects

Journal of Autonomic PharmacologyVolume 9, Issue 1 p. 3-14 Different receptor subtypes mediate the dual presynaptic effects of 5-hydroxytryptamine on peripheral sympathetic neurones E. Adler-Graschinsky, Corresponding Author E. Adler-Graschinsky Instituto de Investigaciones Farmacológicas, CONICET, Junin 956, Buenos Aires, ArgentinaDr E. Adler-Graschinsky.Search for more papers by this authorA. B. Elgoyhen, A. B. Elgoyhen Instituto de Investigaciones Farmacológicas, CONICET, Junin 956, Buenos Aires, ArgentinaSearch for more papers by this authorN. V. Butta, N. V. Butta Instituto de Investigaciones Farmacológicas, CONICET, Junin 956, Buenos Aires, ArgentinaSearch for more papers by this author E. Adler-Graschinsky, Corresponding Author E. Adler-Graschinsky Instituto de Investigaciones Farmacológicas, CONICET, Junin 956, Buenos Aires, ArgentinaDr E. Adler-Graschinsky.Search for more papers by this authorA. B. Elgoyhen, A. B. Elgoyhen Instituto de Investigaciones Farmacológicas, CONICET, Junin 956, Buenos Aires, ArgentinaSearch for more papers by this authorN. V. Butta, N. V. Butta Instituto de Investigaciones Farmacológicas, CONICET, Junin 956, Buenos Aires, ArgentinaSearch for more papers by this author First published: February 1989 https://doi.org/10.1111/j.1474-8673.1989.tb00191.xCitations: 5AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat References Adler-Graschinsky, E. (1983). Dual presynaptic effects of 5-hydroxytryptamine on peripheral noradrenergic synapses. J. Auton. Pharmac. 3, 303–315. Azami, J., Fozard, J. R., Round, A. A. and Wallis, D. I. (1985). The depolarizing action of 5-hydroxytryptamine on rabbit vagal primary afferent and sympathetic neurones and its selective blockade by MDL 72222. Naunyn-Schmiedeberg's Arch. Pharmac. 328, 423–429. Bradley, P. B., Engel, G., Feniuk, W., Fozard, J. R., Humphrey, P. P. A., Middlemiss, D. N., Mylecharane, E. J., Richardson, B. P. and Saxena, P. R. (1986). Proposals for the classification and nomenclature of functional receptors for 5-hydroxytryptamine. Neuropharmac. 25, 563–576. Charlton, K. G., Bond, R. A. and Clarke, D. E. (1986). An inhibitory prejunctional 5-HTI-like receptor in the isolated perfused rat kidney. Apparent distinction from the 5-HT1A, 5-HT1B and 5-HT1C subtypes. Naunyn-Schmiedeberg's Arch. Pharmac. 332, 8–15. Feniuk, W., Humphrey, P. P. A. and Watts, A. D. (1981). Further characterization of pre-and post junctional receptors for 5-hydroxytryptamine in isolated vasculature. Br. J. Pharmac. 73, 191 P. Fozard, J. R. (1984). MDL 72222: a potent and highly selective antagonist at neuronal 5-hydroxytryptamine receptors. Naunyn-Schmiedeberg's Arch. Pharmac. 326, 36–44. Fozard, J. R. and Mobarok ALI, A. T. M. (1978). Blockade of neuronal tryptamine receptors by metoclopramide. Eur. J. Pharmac. 49, 109–112. Fozard, J. R. and Muscholl, E. (1972). Effects of several muscarinic agonists on cardiac performance and the release of noradrenaline from sympathetic nerves of the perfused rabbit heart. Br. J. Pharmac. 45, 616–629. Göthert, M., Kollecker, P., Rohm, N. and Zerkowski, H.-R. (1986). Inhibitory pre-synaptic 5-hydroxytryptamine (5-HT) receptors on the sympathetic nerves of the human saphenous vein. Naunyn-Schmiedeberg's Arch. Pharmac. 332, 317–323. Göthert, M., Schlicker, E. and Kollecker, P. (1986). Receptor-mediated effects of serotonin and 5-methoxytryptamine on noradrenaline release in the rat vena cava and in the heart of the pithed rat. Naunyn-Schmiedeberg's Arch. Pharmac. 332, 124–130. Leysen, J. E., Awouters, F., Kennis, L., Laduron, P. M., Vandenberk, J. and Janssen, P. A. J. (1981). Receptor binding profile of R 41468, a novel antagonist at 5-HT2 receptors. Life Sci. 28, 1015–1022. Löffelholz, K. and Muscholl, E. (1969). A muscarinic inhibition of the noradrenaline release evoked by postganglionic sympathetic nerve stimulation. Naunyn-Schmiedeberg's Arch. Pharmac. 265, 1–15. Middlemiss, D. N. and Fozard, J. R. (1983). 8-Hydroxy-2-(di-n-propylamino)-tetralin discriminates between subtypes of the 5-HT1 recognition site. Eur. J. Pharmac. 90, 151–153. Molderings, G. J., Fink, K., Schlicker, E. and Gothert, M. (1987). Inhibition of noradrenaline release via presynaptic 5-HT1B receptors of the rat vena cava. Naunyn-Schmideberg's Arch. Pharmac. 336, 245–250. Richardson, B. P., Engel, G., Donatsch, P. and Stadler, P. A. (1985). Identification of serotonin M-receptor subtypes and their specific blockade by a new class of drugs. Nature, 316, 126–131. Citing Literature Volume9, Issue1February 1989Pages 3-14 ReferencesRelatedInformation